Topol E J
Cardiac Catheterization Laboratories, University of Michigan Medical Center, Ann Arbor.
Cardiol Clin. 1989 Nov;7(4):827-36.
The past 5 years have witnessed an explosion in the amount of published clinical trial data for the use of intravenous thrombolytic therapy for acute myocardial infarction. This article reviews the properties of the various agents, the experiences of each in prospective, randomized clinical trials, and the future directions of thrombolytic intervention.
在过去5年里,急性心肌梗死静脉溶栓治疗的已发表临床试验数据量呈爆炸式增长。本文回顾了各种药物的特性、每种药物在前瞻性随机临床试验中的经验以及溶栓干预的未来方向。